CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
High real-world effectiveness of elbasvir/grazoprevir (EBR/GZR) in PWID on opioid substitution therapy with HCV genotype 1 (GT1) infection: results from the German Hepatitis C Registry (DHC-R)
DOI 10.1055/s-0039-1695339
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Christensen, A Stoehr, M Cornberg, H Klinker, R Heyne, C John, KG Simon, M Bilzer, V Guenther, V Witte, J Reimer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2019
Jahrgang / SeitenJg. 57
Kernaussage aus der Literatur
Abstract-Vorschau
High real-world effectiveness of elbasvir/grazoprevir (EBR/GZR) in PWID on opioid substitution therapy with HCV genotype 1 (GT1) infection: results from the German Hepatitis C Registry (DHC-R)
Zitieren
Zitierempfehlung
S Christensen, A Stoehr, M Cornberg, H Klinker, R Heyne, C John, KG Simon, M Bilzer, V Guenther, V Witte, J Reimer (2019) High real-world effectiveness of elbasvir/grazoprevir (EBR/GZR) in PWID on opioid substitution therapy with HCV genotype 1 (GT1) infection: results from the German Hepatitis C Registry (DHC-R). Zeitschrift für Gastroenterologie, 57 (09). https://doi.org/10.1055/s-0039-1695339
Mit CareLit weiterarbeiten